| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ADAMAS PHARMACEUTICALS INC | 2,109,099 | 31,932,000 | 9.14% | ||
| 2 | VANDA PHARMACEUTICALS INC COM | 2,705,758 | 30,277,000 | 8.67% | ||
| 3 | SYNERGY PHARMACEUTICALS DEL COM NEW | 7,590,000 | 28,842,000 | 8.26% | ||
| 4 | EXELIXIS INC | 3,200,000 | 24,992,000 | 7.16% | ||
| 5 | DERMIRA INC | 800,000 | 23,400,000 | 6.70% | ||
| 6 | BLUEBIRD BIO INCORPORATED | 500,000 | 21,645,000 | 6.20% | ||
| 7 | NEUROCRINE BIOSCIE COM USD0.001 | 470,000 | 21,362,000 | 6.12% | ||
| 8 | EAGLE PHARMACEUTICALS INC COM | 548,290 | 21,268,000 | 6.09% | ||
| 9 | ZOGENIX INC | 2,440,959 | 19,650,000 | 5.63% | ||
| 10 | IGNYTA INC COM | 3,238,703 | 17,554,000 | 5.03% | ||
| 11 | ENANTA PHARMACEUTICALS INC COM | 538,024 | 11,863,000 | 3.40% | ||
| 12 | SAGE THERAPEUTICS | 330,000 | 9,943,000 | 2.85% | ||
| 13 | TETRAPHASE PHARMACEUTICALS I COM | 2,299,529 | 9,888,000 | 2.83% | ||
| 14 | CONNECTURE INC COM | 4,127,232 | 9,328,000 | 2.67% | ||
| 15 | XENCOR INC COM | 450,000 | 8,546,000 | 2.45% | ||
| 16 | AURINIA PHARMACEUTICALS INC | 2,457,144 | 7,192,000 | 2.06% | ||
| 17 | ALCOBRA LTD | 1,414,573 | 6,351,000 | 1.82% | ||
| 18 | RAPTOR PHARMACEUTICAL CORP | 978,350 | 5,254,000 | 1.50% | ||
| 19 | SAREPTA THERAPEUTICS INC | 238,900 | 4,556,000 | 1.30% | Call | |
| 20 | Sunesis Pharmaceuticals I | 8,173,937 | 4,477,000 | 1.28% | ||
| 21 | Bovie Medical Corp | 2,680,000 | 4,395,000 | 1.26% | ||
| 22 | ARADIGM CORP COM | 1,002,962 | 4,383,000 | 1.26% | ||
| 23 | INTRA CELLULAR THERAPIES INC COM | 100,000 | 3,882,000 | 1.11% | ||
| 24 | OCERA THERAPEUTICS INC | 1,963,777 | 3,731,000 | 1.07% | ||
| 25 | SERES THERAPEUTICS INC | 120,000 | 3,486,000 | 1.00% | Put | |
| 26 | TENAX THERAPEUTICS INC COM | 1,108,593 | 2,838,000 | 0.81% | ||
| 27 | Foamix Pharmaceuticals Ltd. | 274,756 | 1,745,000 | 0.50% | ||
| 28 | ADVERUM BIOTECHNOLOGIES INC | 550,116 | 1,738,000 | 0.50% | ||
| 29 | Ascendis Pharma | 76,511 | 1,015,000 | 0.29% | ||
| 30 | Caladrius Biosciences Inc | 1,525,244 | 900,000 | 0.26% | ||
| 31 | Dipexium Pharmaceuticals Inc | 87,914 | 871,000 | 0.25% | ||
| 32 | VERICEL CORP | 253,502 | 570,000 | 0.16% | ||
| 33 | PARATEK PHARMACEUTICALS INC | 29,266 | 407,000 | 0.12% | ||
| 34 | AXOVANT SCIENCES LTD | 25,000 | 321,000 | 0.09% | ||
| 35 | REVANCE THERAPEUTICS INC COM | 21,665 | 295,000 | 0.08% | ||
| 36 | STREAMLINE HEALTH SOLUTIONS COM | 151,611 | 182,000 | 0.05% | ||
| 37 | RIGEL PHARMACEUTICAL INC | 50,000 | 112,000 | 0.03% | ||
| 38 | ARDELYX INC COM | 3,444 | 30,000 | 0.01% | ||
| 39 | AMARIN CORP PLC | 2,000 | 4,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000930413-16-007885, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
